MORGAN BRINKMAN: Open Payments
NPI 1285225706 · BOONE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,010 in 74 payments from 14 companies in 2025. Trend: 2023 $1,338 · 2024 $2,258 · 2025 $2,010
Food & beverage: $2,010
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $325 |
| PFIZER INC. | 18 | $283 |
| GENZYME CORPORATION | 4 | $282 |
| Madrigal Pharmaceuticals | 3 | $252 |
| Ardelyx, Inc. | 9 | $208 |
| Lilly USA, LLC | 3 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $129 |
| Ipsen Biopharmaceuticals, Inc | 1 | $113 |
| Janssen Biotech, Inc. | 3 | $74 |
| Aimmune Therapeutics, Inc. | 4 | $72 |
Products named: DUPIXENT, REZDIFFRA, IBSRELA, XELJANZ, OMVOH, RINVOQ, IQIRVO, VELSIPITY.
Industry payments across NC — which companies pay providers there.
